The DOI matches its Crossref record; 125 of the 125 references it cites were found in a registry or an index.
Interplay between inflammation and cancer
Abstract
During the 19th century, for the first time, the linkage between inflammation and cancer was established. Inflammatory microenvironment is an essential component of the tumor microenvironment. Chronic inflammation due to persistent infection due to the microbes, viruses, helminths or constant exposure to non-infectious factors like smoke, silica or asbestos eventually might result in carcinogenesis. In tumor microenvironment, various inflammatory cells such as T lymphocytes (occasionally B cells), dendritic cells, macrophages, monocytes, neutrophils and natural killer (NK) cells are present. As a mediator of immune surveillance and host defense TRAIL cytokines are produced which upon binding with death receptors (DRs) initiate a cascade of apoptotic pathways. Anti-inflammatory drugs such as aspirin, celecoxib, diclofenac, diflunisal and ibuprofen etc. are being used against cancer, indicating the interplay between both the mechanisms. A deeper understanding of common pathways implicated between both the inflammation and cancer may pave the way to fight against both of these deleterious ailments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Sung, B., Park, B., Yadav, V. R., & Aggarwal, B. B. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.090209 · Cited by 123
RetractedPrasad, S., Ravindran, J., Sung, B., Pandey, M. K., & Aggarwal, B. B. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-1113 · Cited by 79
RetractedCoussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Microenvironmental regulation of tumor progression and metastasis
Quail, D. F., & Joyce, J. A. (2013) · Nature Medicine · doi:10.1038/nm.3394 · Cited by 7,994
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
Oncology meets immunology: the cancer-immunity cycle.
Chen, D. S., & Mellman, I. (2013) · Immunity · doi:10.1016/j.immuni.2013.07.012 · Cited by 6,929
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
Galon, J., Costes, A., Sanchez-Cabo, F., Kirilovsky, A., Mlecnik, B., Lagorce-Pagès, C., Tosolini, M., Camus, M., Berger, A., Wind, P., et al. (2006) · Science · doi:10.1126/science.1129139 · Cited by 6,516
Macrophage activation and polarization: nomenclature and experimental guidelines
Murray, P. J., Allen, J. E., Biswas, S. K., Fisher, E. A., Gilroy, D. W., Goerdt, S., Gordon, S., Hamilton, J. A., Ivashkiv, L. B., Lawrence, T., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.008 · Cited by 6,337
Alternative activation of macrophages: mechanism and functions
Gordon, S., & Martinez, F. O. (2010) · Immunity · doi:10.1016/j.immuni.2010.05.007 · Cited by 4,197
Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TAN
Fridlender, Z. G., Sun, J., Kim, S., Kapoor, V., Cheng, G., Ling, L., Worthen, G. S., & Albelda, S. M. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.06.017 · Cited by 3,371
Development of Monocytes, Macrophages, and Dendritic Cells
Geissmann, F., Manz, M. G., Jung, S., Sieweke, M. H., Merad, M., & Ley, K. (2010) · Science · doi:10.1126/science.1178331 · Cited by 3,049
Role of C-Reactive Protein at Sites of Inflammation and Infection
Sproston, N. R., & Ashworth, J. J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00754 · Cited by 3,029
CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis
Qian, B.-Z., Li, J., Zhang, H., Kitamura, T., Zhang, J., Campion, L. R., Kaiser, E. A., Snyder, L. A., & Pollard, J. W. (2011) · Nature · doi:10.1038/nature10138 · Cited by 2,874
Colley, D. G., Bustinduy, A. L., Secor, W. E., & King, C. H. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61949-2 · Cited by 2,444
Macrophage plasticity and polarization in tissue repair and remodelling
Mantovani, A., Biswas, S. K., Galdiero, M. R., Sica, A., & Locati, M. (2013) · The Journal of Pathology · doi:10.1002/path.4133 · Cited by 2,384
DeNardo, D. G., Brennan, D. J., Rexhepaj, E., Ruffell, B., Shiao, S. L., Madden, S. F., Gallagher, W. M., Wadhwani, N., Keil, S. D., Junaid, S. A., et al. (2011) · Cancer Discovery · doi:10.1158/2159-8274.cd-10-0028 · Cited by 1,715
Zanganeh, S., Hutter, G., Spitler, R., Lenkov, O., Mahmoudi, M., Shaw, A., Pajarinen, J. S., Nejadnik, H., Goodman, S., Moseley, M., et al. (2016) · Nature Nanotechnology · doi:10.1038/nnano.2016.168 · Cited by 1,647
IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses
Krausgruber, T., Blazek, K., Smallie, T., Alzabin, S., Lockstone, H., Sahgal, N., Hussell, T., Feldmann, M., & Udalova, I. A. (2011) · Nature Immunology · doi:10.1038/ni.1990 · Cited by 1,306
Dangerous liaisons: STAT3 and NF-κB collaboration and crosstalk in cancer
Grivennikov, S. I., & Karin, M. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2009.11.005 · Cited by 1,160
Role of interleukin-6 in cancer progression and therapeutic resistance
Kumari, N., Dwarakanath, B. S., Das, A., & Bhatt, A. N. (2016) · Tumor Biology · doi:10.1007/s13277-016-5098-7 · Cited by 1,092
Inflammation, a Key Event in Cancer Development
Lu, H., Ouyang, W., & Huang, C. (2006) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-05-0261 · Cited by 1,028
Natural killer cells and other innate lymphoid cells in cancer
Chiossone, L., Dumas, P.-Y., Vienne, M., & Vivier, E. (2018) · Nature Reviews Immunology · doi:10.1038/s41577-018-0061-z · Cited by 1,007
Mitchem, J. B., Brennan, D. J., Knolhoff, B. L., Belt, B. A., Zhu, Y., Sanford, D. E., Belaygorod, L., Carpenter, D., Collins, L., Piwnica-Worms, D., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2731 · Cited by 943
Foell, D., Wittkowski, H., Vogl, T., & Roth, J. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0306170 · Cited by 879
Bruchard, M., Mignot, G., Derangère, V., Chalmin, F., Chevriaux, A., Végran, F., Boireau, W., Simon, B., Ryffel, B., Connat, J. L., et al. (2013) · Nature Medicine · doi:10.1038/nm.2999 · Cited by 774
Gocheva, V., Wang, H.-W., Gadea, B. B., Shree, T., Hunter, K. E., Garfall, A. L., Berman, T., & Joyce, J. A. (2010) · Genes & Development · doi:10.1101/gad.1874010 · Cited by 740
Tumor-associated neutrophils: friend or foe?
Fridlender, Z. G., & Albelda, S. M. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs123 · Cited by 699
Pierce, B. L., Ballard-Barbash, R., Bernstein, L., Baumgartner, R. N., Neuhouser, M. L., Wener, M. H., Baumgartner, K. B., Gilliland, F. D., Sorensen, B. E., McTiernan, A., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.9068 · Cited by 691
Interleukin-8 and human cancer biology
Xie, K. (2001) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(01)00016-8 · Cited by 689
Cellular and Molecular Identity of Tumor-Associated Macrophages in Glioblastoma
Chen, Z., Feng, X., Herting, C. J., Garcia, V. A., Nie, K., Pong, W. W., Rasmussen, R., Dwivedi, B., Seby, S., Wolf, S. A., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2310 · Cited by 675
Qian, B., Deng, Y., Im, J. H., Muschel, R. J., Zou, Y., Li, J., Lang, R. A., & Pollard, J. W. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006562 · Cited by 664
A Proinflammatory Cytokine Inhibits P53 Tumor Suppressor Activity
Hudson, J. D., Shoaibi, M. A., Maestro, R., Carnero, A., Hannon, G. J., & Beach, D. H. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.10.1375 · Cited by 649
Murata, M. (2018) · Environmental Health and Preventive Medicine · doi:10.1186/s12199-018-0740-1 · Cited by 588
Gritsko, T., Williams, A., Turkson, J., Kaneko, S., Bowman, T., Huang, M., Nam, S., Eweis, I., Diaz, N., Sullivan, D., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1752 · Cited by 563
Sanmamed, M. F., Perez-Gracia, J. L., Schalper, K. A., Fusco, J. P., Gonzalez, A., Rodriguez-Ruiz, M. E., Oñate, C., Perez, G., Alfaro, C., Martín-Algarra, S., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx190 · Cited by 458
Molina, M. A., Sitjà, M., Lemoine, M. G., Frazier, M. L., & Sinicrope, F. A. (1999) · PubMed · Cited by 404
Inhibition of CXCR2 profoundly suppresses inflammation-driven and spontaneous tumorigenesis
Jamieson, T., Clarke, M., Steele, C. W., Samuel, M. S., Neumann, J., Jung, A., Huels, D., Olson, M. F., Das, S., Nibbs, R. J. B., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci61067 · Cited by 391
Interleukin-8 in cancer pathogenesis, treatment and follow-up
Alfaro, C., Sanmamed, M. F., Rodríguez-Ruiz, M. E., Teijeira, Á., Oñate, C., González, Á., Ponz, M., Schalper, K. A., Pérez-Gracia, J. L., & Melero, I. (2017) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2017.08.004 · Cited by 372
Dijkgraaf, E. M., Heusinkveld, M., Tummers, B., Vogelpoel, L. T. C., Goedemans, R., Jha, V., Nortier, J. W. R., Welters, M. J. P., Kroep, J. R., & van der Burg, S. H. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3542 · Cited by 346
Fridlender, Z. G., Sun, J., Mishalian, I., Singhal, S., Cheng, G., Kapoor, V., Horng, W., Fridlender, G., Bayuh, R., Worthen, G. S., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031524 · Cited by 311
Chen, J. J. W., Yao, P., Yuan, A., Hong, T.-M., Shun, C., Kuo, M., Lee, Y.-C., & Yang, P. (2003) · PubMed · Cited by 308
Bronger, H., Singer, J., Windmüller, C., Reuning, U., Zech, D., Delbridge, C., Dorn, J., Kiechle, M., Schmalfeldt, B., Schmitt, M., et al. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.172 · Cited by 274
Mishalian, I., Bayuh, R., Eruslanov, E., Michaeli, J., Levy, L., Zolotarov, L., Singhal, S., Albelda, S. M., Granot, Z., & Fridlender, Z. G. (2014) · International Journal of Cancer · doi:10.1002/ijc.28770 · Cited by 253
Jung, E. M., Lim, J. H., Lee, T. J., Park, J.-W., Choi, K. S., & Kwon, T. K. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi167 · Cited by 240
NF‐κB activation in development and progression of cancer
Inoue, J., Gohda, J., Akiyama, T., & Semba, K. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00389.x · Cited by 235
Paulus, P., Stanley, E. R., Schäfer, R., Abraham, D., & Aharinejad, S. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3523 · Cited by 231
Colibactin: More Than a New Bacterial Toxin
Faïs, T., Delmas, J., Barnich, N., Bonnet, R., & Dalmasso, G. (2018) · Toxins · doi:10.3390/toxins10040151 · Cited by 227
Helicobacter pylori and Gastric Cancer: Adaptive Cellular Mechanisms Involved in Disease Progression
Díaz, P., Valenzuela Valderrama, M., Bravo, J., & Quest, A. F. G. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00005 · Cited by 226
Chemokines beyond chemo-attraction: CXCL10 and its significant role in cancer and autoimmunity
Karin, N., & Razon, H. (2018) · Cytokine · doi:10.1016/j.cyto.2018.02.012 · Cited by 222
Coffelt, S. B., Chen, Y.-Y., Muthana, M., Welford, A. F., Tal, A. O., Scholz, A., Plate, K. H., Reiss, Y., Murdoch, C., De Palma, M., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002802 · Cited by 220
Mizutani, K., Sud, S., McGregor, N. A., Martinovski, G., Rice, B. T., Craig, M. J., Varsos, Z. S., Roca, H., & Pienta, K. J. (2009) · Neoplasia · doi:10.1593/neo.09988 · Cited by 220
Immune Cell Gene Signatures for Profiling the Microenvironment of Solid Tumors
Nirmal, A. J., Regan, T., Shih, B. B., Hume, D. A., Sims, A. H., & Freeman, T. C. (2018) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-18-0342 · Cited by 218
IL-23 in inflammatory bowel diseases and colon cancer
Neurath, M. F. (2019) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2018.12.002 · Cited by 214
DNA Damage in Inflammation-Related Carcinogenesis and Cancer Stem Cells
Ohnishi, S., Ma, N., Thanan, R., Pinlaor, S., Hammam, O., Murata, M., & Kawanishi, S. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/387014 · Cited by 207
Hypoxia and Inflammation in Cancer, Focus on HIF and NF-κB
D’Ignazio, L., Batie, M., & Rocha, S. (2017) · Biomedicines · doi:10.3390/biomedicines5020021 · Cited by 205
Cellular and molecular mechanisms of inflammation‐induced angiogenesis
Szade, A., Grochot‐Przeczek, A., Florczyk, U., Jozkowicz, A., & Dulak, J. (2015) · IUBMB Life · doi:10.1002/iub.1358 · Cited by 199
Truxova, I., Kasikova, L., Hensler, M., Skapa, P., Laco, J., Pecen, L., Belicova, L., Praznovec, I., Halaska, M. J., Brtnicky, T., et al. (2018) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-018-0446-3 · Cited by 191
Human T-cell leukemia virus type I (HTLV-I) infection and the onset of adult T-cell leukemia (ATL)
Matsuoka, M. (2005) · Retrovirology · doi:10.1186/1742-4690-2-27 · Cited by 186
Interleukin‐6 promotes tumorigenesis by altering DNA methylation in oral cancer cells
Gasche, J. A., Hoffmann, J., Boland, C. R., & Goel, A. (2011) · International Journal of Cancer · doi:10.1002/ijc.25764 · Cited by 178
Kaposi sarcoma herpesvirus-associated cancers and related diseases
Goncalves, P. H., Ziegelbauer, J., Uldrick, T. S., & Yarchoan, R. (2017) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000330 · Cited by 174
COX-2 overexpression increases motility and invasion of breast cancer cells
Singh, B., Berry, J., Shoher, A., Ramakrishnan, V., & Lucci, A. (2005) · International Journal of Oncology · doi:10.3892/ijo.26.5.1393 · Cited by 173
Sandel, M. H., Dadabayev, A. R., Menon, A. G., Morreau, H., Melief, C. J. M., Offringa, R., van der Burg, S. H., Janssen-van Rhijn, C. M., Ensink, N. G., Tollenaar, R. A. E. M., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1448 · Cited by 173
Liu, C., Lin, J., Hsu, T., Su, K., Li, A. F., Hsu, H., & Hung, S. (2015) · International Journal of Cancer · doi:10.1002/ijc.29033 · Cited by 169
Salvagno, C., Ciampricotti, M., Tuit, S., Hau, C.-S., van Weverwijk, A., Coffelt, S. B., Kersten, K., Vrijland, K., Kos, K., Ulas, T., et al. (2019) · Nature Cell Biology · doi:10.1038/s41556-019-0298-1 · Cited by 168
Chen, C., Xu, Z., Zong, Y., Ou, B., Shen, X., Feng, H., Zheng, M., Zhao, J., & Lu, A. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1431-6 · Cited by 167
Iron induces anti-tumor activity in tumor-associated macrophages
Costa da Silva, M., Breckwoldt, M. O., Vinchi, F., Correia, M. P., Stojanovic, A., Thielmann, C. M., Meister, M., Muley, T., Warth, A., Platten, M., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01479 · Cited by 164
Reichert, T. E., Scheuer, C., Day, R., Wagner, W., & Whiteside, T. L. (2001) · Cancer · doi:10.1002/1097-0142(20010601)91:11<2136::aid-cncr1242>3.0.co;2-q · Cited by 162
LONG, X., Ye, Y., Zhang, L., Liu, P., Yu, W., Wei, F., Ren, X., & Yu, J. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.3234 · Cited by 162
Interleukin (IL)-12 and IL-23 and Their Conflicting Roles in CancerPreprint
Yan, J., Smyth, M. J., & Teng, M. W. L. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a028530 · Cited by 161
The effects of monocytes on tumor cell extravasation in a 3D vascularized microfluidic model
Boussommier-Calleja, A., Atiyas, Y., Haase, K., Headley, M., Lewis, C., & Kamm, R. D. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2018.03.005 · Cited by 158
Iwahashi (2011) · Oncology Reports · doi:10.3892/or.2011.1201 · Cited by 149
Ong, S., Tan, Y., Beretta, O., Jiang, D., Yeap, W., Tai, J. J. Y., Wong, W., Yang, H., Schwarz, H., Lim, K., et al. (2012) · European Journal of Immunology · doi:10.1002/eji.201141825 · Cited by 145
Chakraborty, A., Gupta, N., Ghosh, K., & Roy, P. (2010) · Toxicology in Vitro · doi:10.1016/j.tiv.2010.02.007 · Cited by 139
Shankar, S., Ganapathy, S., & Srivastava, R. K. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0903 · Cited by 137
Luteolin Promotes Cell Apoptosis by Inducing Autophagy in Hepatocellular Carcinoma
Cao, Z., Zhang, H., Cai, X., Fang, W. Y., Chai, D., Wen, Y., Chen, H., Chu, F., & Zhang, Y. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000484066 · Cited by 134
miR-126 promotes angiogenesis and attenuates inflammation after contusion spinal cord injury in rats
Hu, J., Zeng, L., Huang, J., Wang, G., & Lü, H. (2015) · Brain Research · doi:10.1016/j.brainres.2015.02.036 · Cited by 133
Taniguchi, H., Yoshida, T., Horinaka, M., Yasuda, T., Goda, A. E., Konishi, M., Wakada, M., Kataoka, K., Yoshikawa, T., & Sakai, T. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1120 · Cited by 132
Overexpression of CXCL1 and its receptor CXCR2 promote tumor invasion in gastric cancer
Cheng, W.-P., Wang, C. S., Huang, Y., Tsai, M.-M., Liang, Y. J., & Lin, K. (2011) · Annals of Oncology · doi:10.1093/annonc/mdq739 · Cited by 128
Chen, M., Wang, X., Zha, D., Cai, F., Zhang, W., He, Y., Huang, Q., Zhuang, H., & Hua, Z. (2016) · Scientific Reports · doi:10.1038/srep35468 · Cited by 126
Frédéric Thomas, A., Lafferty, K. D., Jacques Brodeur, B., Elguero, É., Gauthier‐Clerc, M., & Missé, D. (2011) · Biology Letters · doi:10.1098/rsbl.2011.0588 · Cited by 123
Clinical and experimental approaches to the pathophysiology of interleukin-18 in cancer progression
Vidal‐Vanaclocha, F., Mendoza, L., Tellería, N., Salado, C., Valcárcel, M., Gallot, N., Carrascal, T., Egilegor, E., Beaskoetxea, J., & Dinarello, C. A. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-9013-3 · Cited by 122
Shankar, S., Ganapathy, S., & Srivastava, R. K. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-3596 · Cited by 121
Biological and genetic properties of the p53 null preneoplastic mammary epithelium
Medina, D., Kittrell, F. S., Shepard, A., Stephens, L. C., Jiang, C., Lü, J., Allred, D. C., McCarthy, M. P., & Ullrich, R. L. (2002) · The FASEB Journal · doi:10.1096/fj.01-0885fje · Cited by 114
A Survey on the Role of Interleukin-10 in Breast Cancer: A Narrative.
Sheikhpour, E., Noorbakhsh, P., Foroughi, E., Farahnak, S., Nasiri, R., & Neámatzadeh, H. (2018) · Europe PMC (PubMed Central) · Cited by 111
Wogonin sensitizes resistant malignant cells to TNFα- and TRAIL-induced apoptosis
Fas, S. C., Baumann, S., Zhu, J. Y., Giaisi, M., Treiber, M. K., Mahlknecht, U., Krammer, P. H., & Li‐Weber, M. (2006) · Blood · doi:10.1182/blood-2006-03-011973 · Cited by 109
Lee, T.-J., Um, H. J., Min, D. S., Park, J. W., Choi, K. S., & Kwon, T. K. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.03.022 · Cited by 108
Feldmeyer, L., Hudgens, C. W., Ray-Lyons, G., Nagarajan, P., Aung, P. P., Curry, J. L., Torres-Cabala, C. A., Mino, B., Rodriguez‐Canales, J., Reuben, A., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0392 · Cited by 108
Changes in transcriptome of macrophages in atherosclerosis
Chistiakov, D. A., Bobryshev, Y. V., & Orekhov, A. N. (2015) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12591 · Cited by 105
CXCL8 and Its Cognate Receptors in Melanoma Progression and Metastasis
Singh, S., Singh, A. P., Sharma, B., Owen, L. B., & Singh, R. K. (2009) · Future Oncology · doi:10.2217/fon.09.128 · Cited by 104
Virus induced inflammation and cancer development
Read, S. A., & Douglas, M. W. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.07.030 · Cited by 99
CXCR5, the Defining Marker for Follicular B Helper T (TFH) Cells
Moser, B. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00296 · Cited by 97
Liguori, M., Buracchi, C., Pasqualini, F., Bergomas, F., Pesce, S., Sironi, M., Grizzi, F., Mantovani, A., Belgiovine, C., & Allavena, P. (2016) · Oncotarget · doi:10.18632/oncotarget.9340 · Cited by 94
TRAIL combinations: The new ‘trail’ for cancer therapy (Review)
Refaat, A., Abdrabou, A., & Reda, A. M. (2014) · Oncology Letters · doi:10.3892/ol.2014.1922 · Cited by 87
Gao, Y., Yin, J., Rankin, G. O., & Chen, Y. (2018) · Molecules · doi:10.3390/molecules23051095 · Cited by 79
Deciphering the Message Broadcast by Tumor-Infiltrating Dendritic Cells
Karthaus, N., Torensma, R., & Tel, J. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.05.012 · Cited by 78
Hasegawa, H. (2005) · Blood · doi:10.1182/blood-2005-05-1982 · Cited by 76
Induction of apoptosis by pinostrobin in human cervical cancer cells: Possible mechanism of action
Jaudan, A., Sharma, S., Malek, S. N. A., & Dixit, A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0191523 · Cited by 76
Macrophages promote the progression of premalignant mammary lesions to invasive cancer
Carron, E. C., Homra, S., Rosenberg, J. N., Coffelt, S. B., Kittrell, F. S., Zhang, Y., Creighton, C. J., Fuqua, S. A. W., Medina, D., & Machado, H. L. (2017) · Oncotarget · doi:10.18632/oncotarget.14913 · Cited by 75
Nie, W., Yu, T., Sang, Y., & Gao, X. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.12.048 · Cited by 74
Serum antibodies to Trichomonas vaginalis in invasive cervical cancer patients.
Yap, E. H., Ho, T. H., Chan, Y. C., Thong, T. W. J., Ng, G. C., Ho, L. C., & Singh, M. (1995) · Sexually Transmitted Infections · doi:10.1136/sti.71.6.402 · Cited by 71
Piperine enhances the efficacy of TRAIL-based therapy for triple-negative breast cancer cells.
Abdelhamed, S., Yokoyama, S., Refaat, A., Ogura, K., Yagita∥, H., Awale, S., & Saiki, I. (2014) · PubMed · Cited by 69
A Critical Role for the Inflammatory Response in a Mouse Model of Preneoplastic Progression
Schwertfeger, K. L., Xian, W., Kaplan, A. M., Burnett, S. H., Cohen, D. A., & Rosen, J. M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3781 · Cited by 65
Yang, J.-M., Hung, C., Fu, C.-N., Lee, J., Huang, C.-H., Yang, M., Lin, C., Kao, J., & Way, T. (2010) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf102304g · Cited by 63
Targeting death receptors for TRAIL by agents designed by Mother Nature
Prasad, S., Kim, J. H., Gupta, S. C., & Aggarwal, B. B. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.07.004 · Cited by 62
Liang, Y., Xu, R.-Z., Zhang, L., & Zhao, X.-Y. (2009) · Acta Pharmacologica Sinica · doi:10.1038/aps.2009.167 · Cited by 61
Mucin-like peptides from Echinococcus granulosus induce antitumor activity
Noya, V., Bay, S., Festari, M. F., GARCÍA, E. P., Rodríguez, E., Chiale, C., Ganneau, C., Baleux, F., Astrada, S., Bollati‐Fogolín, M., et al. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.2000 · Cited by 54
Causal role of infectious agents in cancer: An overview.
Masrour-Roudsari, J., & Ebrahimpour, S. (2017) · PubMed Central · doi:10.22088/cjim.8.3.153 · Cited by 54
Prognostic significance of CXCL5 expression in cancer patients: a meta-analysis
Hu, B., Fan, H., Lv, X., Chen, S., & Shao, Z. (2018) · Cancer Cell International · doi:10.1186/s12935-018-0562-7 · Cited by 54
Au, K. K., Peterson, N. T., Truesdell, P. F., Reid‐Schachter, G., Khalaj, K., Ren, R., Francis, J., Graham, C. H., Craig, A. W., & Koti, M. (2017) · Gynecologic Oncology · doi:10.1016/j.ygyno.2017.03.007 · Cited by 53
Berbamine Exerts Anti-Inflammatory Effects via Inhibition of NF-κB and MAPK Signaling Pathways
Jia, X., Li, X., Wang, F., Liu, H., & Zhang, D. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000475650 · Cited by 53
The Role of Epstein–Barr Virus in Cervical Cancer: A Brief Update
Vranić, S., Cyprian, F., Akhtar, S., & Moustafa, A.-E. A. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00113 · Cited by 53
Katz, C., Zaltsman-Amir, Y., Mostizky, Y., Kollet, N., Gross, A., & Friedler, A. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.328377 · Cited by 47
Editorial: Secretion of Cytokines and Chemokines by Innate Immune Cells
Lacy, P. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00190 · Cited by 45
Ledesma‐Soto, Y., Callejas, B. E., Terrazas, C. A., Reyes, J. L., Espinoza-Jiménez, A., González, M. I., León‐Cabrera, S., Morales, R., Olguín, J. E., Saavedra, R., et al. (2015) · BioMed Research International · doi:10.1155/2015/563425 · Cited by 43
Ramirez‐Garcia, A., Arteta, B., Abad, A., Pellón, A., Antoran, A., Márquez, J., Rementería, A., & Hernando, F. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053584 · Cited by 39
In Vitro and in Vivo Antitumor Evaluation of Berbamine for Lung Cancer Treatment
Hou, Z., Lu, K., Wu, X., Chen, C., Huang, X., & Yin, H.-T. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.4.1767 · Cited by 39
Reduction in CD1d expression on dendritic cells and macrophages by an acute virus infection
Lin, Y., Webb, T. J., Spence, P. M., & Brutkiewicz, R. R. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0704399 · Cited by 38
Ke, R., Vishnoi, K., Viswakarma, N., Santha, S., Das, S., Rana, A., & Rana, B. (2018) · Scientific Reports · doi:10.1038/s41598-018-23780-x · Cited by 33
Regulative role of the CXCL13-CXCR5 axis in the tumor microenvironment
Tan, P., Shi, M., Lai, L., Tang, Z., Xie, N., Xu, H., Wei, Q., Zhang, X., Yang, L., & Wu, L. (2018) · Precision Clinical Medicine · doi:10.1093/pcmedi/pby006 · Cited by 25
Malietzis, G. A., Lee, G. H., Jenkins, J. T., Bernardo, D., Moorghen, M., Knight, S. C., & Al-Hassi, H. O. (2015) · Cell Communication & Adhesion · doi:10.3109/15419061.2015.1036859 · Cited by 22
Trinh, V. N., Dang, N. D.-P., Tran, D. H., & Pham, P. V. (2016) · Biomedical Research and Therapy · doi:10.7603/s40730-016-0034-4 · Cited by 19
The Local Tumor Microenvironment
Whiteside, T. L. (2007) · Springer eBooks · doi:10.1007/978-1-4020-6087-8_7 · Cited by 17
Poiroux, G., Barre, A., Simplicien, M., Pélofy, S., Ségui, B., Damme, E. J. M. V., Rougé, P., & Benoist, H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20010230 · Cited by 16
General Principles of Tumor Immunotherapy: Basic and Clinical Applications of Tumor Immunology
Kaufman, H. L., & Wolchok, J. D. (2007) · Springer eBooks · doi:10.1007/978-1-4020-6087-8 · Cited by 15
General principles of tumor immunotherapy : basic and clinical applications of tumor immunology
Wolchok, J. D., & Kaufman, H. L. (2007) · Medical Entomology and Zoology · Cited by 11
Cited by
Li, L., Yu, R., Cai, T., Chen, Z., Lan, M., Zou, T., Wang, B., Wang, Q., Zhao, Y., & Cai, Y. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106939 · Cited by 381
Hu, X., Chen, Y., Shen, Y., Tian, R., Sheng, Y., & Que, H. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.1020709 · Cited by 279
Asbestos fibers promote iron oxidation and Compete with apoferritin enzymatic activity
Zangari, M., Borelli, V., Bernareggi, A., & Zabucchi, G. (2023) · Journal of Toxicology and Environmental Health, Part A · doi:10.1080/15287394.2022.2164391 · Cited by 5
Metadata
- Venue
- Advances in Protein Chemistry and Structural Biology
- Publisher
- Elsevier
- Published
- 2020
- Volume
- 119
- Pages
- 199-245
- ISSN
- 1876-1623 (ISSN-L)
- OpenAlex
- W2990579199
- Cited by
- 290
- References
- 125
- FWCI
- 31.96
- Type
- book chapter
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.